Rheumatic and musculoskeletal disorders (RMDs) like arthritis are having a significant impact on how long people across ...

START will leverage Trialing’s platform to distribute curated information on ongoing early-phase oncology trials.

The U.S. FDA granted marketing authorization for ProSense in October 2025 for use in low-risk early-stage breast cancer, specifically for women aged 70 and over or those unsuitable for surgery. Market ...

Led by researchers at NDORMS as part of the Data Analysis and Real World Interrogation Network (DARWIN EU) initiative, a new ...

IceCure Medical Ltd. (Nasdaq: ICCM) ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive ...

Among the 66 men who completed full datasets, the results showed clear improvements in those using the app vs the control ...

Built in Germany with the highest medical quality standards, Onno now brings this service to English speakers.

The Euronews Health Summit 2026 gathers policymakers, innovators, and patient advocates to tackle the continent's most pressing healthcare challenges. View on euronews ...

There was a doctor in Chicago years ago named Victor Frankenstein, and one of his jobs was finding medical specimens. When ...

Record 4th quarter and full year sales of $1.3 million and $3.4 million, respectively Strong commercial momentum for ProSense® in the U.S. and globally following FDA ...

The double-blind, randomised, placebo-controlled trial will assess the efficacy and safety of Livmarli in both children and ...

Researchers show that pharmacological activation of hypoxia signaling improves metabolism, limits fat accumulation, and ...